This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Invitrogen
other brands :
NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience
product type :
antibody
product name :
PEA15 Polyclonal Antibody
catalog :
PA5-43145
quantity :
100 uL
price :
US 464.00
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human
application :
western blot
product information
Product Type :
Antibody
Product Name :
PEA15 Polyclonal Antibody
Catalog # :
PA5-43145
Quantity :
100 uL
Price :
US 464.00
Clonality :
Polyclonal
Purity :
Affinity Chromatography
Host :
Rabbit
Reactivity :
Human
Applications :
Western Blot: 1:1,000
Species :
Human
Isotype :
IgG
Storage :
-20 C, Avoid Freeze/Thaw Cycles
Description :
PEA15 is a death effector domain (DED)-containing protein predominantly expressed in the central nervous system, particularly in astrocytes.
Immunogen :
Synthetic peptide directed towards the middle region of human PEA15
Format :
Liquid
Applications w/Dilutions :
Western Blot: 1:1,000
Aliases :
15 kDa phosphoprotein enriched in astrocytes; astrocytic phosphoprotein PEA-15; HMAT1; homolog of mouse MAT-1 oncogene; HUMMAT1H; mammary transforming gene 1; mammary transforming gene 1, mouse, homolog of; MAT1; MAT1H; OTTHUMP00000029887; Pea15; PEA-15; Pea15a; PED; phosphoprotein enriched in astrocytes 15; phosphoprotein enriched in astrocytes 15A; phosphoprotein enriched in diabetes; Pkcs15; proliferation and apoptosis adaptor protein 15
company information
Invitrogen
Thermo Fisher Scientific
81 Wyman Street
Waltham, MA USA 02451
https://www.thermofisher.com81 Wyman Street
Waltham, MA USA 02451
800-678-5599
headquarters: USA
questions and comments